Brain Tumor Treatments: Utah

Sponsored By

Please Click On The Above Banner For More Details

Search Term: Utah
Please scroll down to see the matching trials.

  (0.8351) Brain Tumor Treatments: Utah
  (0.7742) Doctor / Hospital Address Book
  (0.7742) Brain Tumor Activism
  (0.7742) Letter Writing Wizard
  (0.7742) Brain Tumor Activism
  (0.7742) Gliadel® Doctors: Alphabetical
  (0.7742) Untitled Document
  (0.7742) Brain Tumor Treatments: Gene Therapy

Sorry - There were no pages found that contain that search phrase.


	Showing Treatment 1 to 18 of 18	Location	Last Updated

Details	Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme	Salt Lake City, UT USA	08/11/2009

Details	Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)	Salt Lake City, UT USA	01/31/2009

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Murray, UT USA	04/11/2008

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Saint George, UT USA	04/11/2008

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Salt Lake City, UT USA	04/11/2008

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Ogden, UT USA	04/11/2008

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Provo, UT USA	04/11/2008

Details	A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas	Salt Lake City, UT USA	05/01/2007

Details	Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer	Salt Lake City, UT USA	05/01/2007

Details	Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma	Salt Lake City, UT USA	05/30/2006

Details	Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme	Murray, UT USA	05/29/2006

Details	Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme	Saint George, UT USA	05/29/2006

Details	Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme	Ogden, UT USA	05/29/2006

Details	Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme	Provo, UT USA	05/29/2006

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Salt Lake City, UT USA	11/27/2005

Details	Long-term survivors of high grade gliomas.	Salt Lake City, UT USA	11/24/2005

Details	A trial of Dalteparin low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients.	Salt Lake City, UT USA	11/24/2005

Details	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	Salt Lake City, UT USA	11/06/2005

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By